DETECT BIOSCIENCES, LLC

Basic Information

242 E 33RD ST
NEW YORK, NY, 10016-8017

Company Profile

n/a

Additional Details

Field Value
DUNS: 826051687
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: n/a


  1. Development of a Peptidomic Rapid Point-of-Care TB Diagnostic

    Amount: $1,035,199.00

    DESCRIPTION (provided by applicant): Diagnosis of active tuberculosis (TB) in TB-endemic countries, where gt90% of the global TB cases occur, depends upon microscopic examination of sputum smears made ...

    STTR Phase II 2013 Department of Health and Human Services
  2. Development of a Peptidomic Rapid Point-of-Care TB Diagnostic

    Amount: $524,856.00

    DESCRIPTION (provided by applicant): The goals of this proposal are to devise rapid serological tests that can replace the sputum smear test for the diagnosis of active TB and meets the WHO specificat ...

    STTR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government